These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3797582)

  • 21. [The relation between behavioral sensitization and glutamate release on the animal model of methamphetamine-induced psychosis].
    Honda M
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):65-78. PubMed ID: 14978976
    [No Abstract]   [Full Text] [Related]  

  • 22. Long lasting behavioral effects of dimethyl sulfoxide and the "peripheral" toxicant p-bromophenylacetylurea.
    Fossom LH; Messing RB; Sparber SB
    Neurotoxicology; 1985; 6(1):17-28. PubMed ID: 3873034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
    Byrnes-Blake KA; Laurenzana EM; Landes RD; Gentry WB; Owens SM
    Eur J Pharmacol; 2005 Oct; 521(1-3):86-94. PubMed ID: 16182279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
    Häggkvist J; Lindholm S; Franck J
    Addict Biol; 2009 Jul; 14(3):260-9. PubMed ID: 19298318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphetamine: a pharmacological profile.
    Aboul-Enein HY
    Am J Pharm Sci Support Public Health; 1971; 143(5):161-4. PubMed ID: 5003217
    [No Abstract]   [Full Text] [Related]  

  • 26. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of glutamic acid on operant behavior, activity, and open-field behavior in rats.
    Agruso VM; Matthews MD
    Psychol Rep; 1985 Dec; 57(3 Pt 1):1003-4. PubMed ID: 2867571
    [No Abstract]   [Full Text] [Related]  

  • 29. Stereotyped activities produced by amphetamine in several animal species and man.
    Randrup A; Munkvad I
    Psychopharmacologia; 1967; 11(4):300-10. PubMed ID: 4968376
    [No Abstract]   [Full Text] [Related]  

  • 30. A silicone pellet for continuous cocaine: comparison with continuous amphetamine.
    Lipton J; Zeigler S; Wilkins J; Ellison G
    Pharmacol Biochem Behav; 1991 Apr; 38(4):927-30. PubMed ID: 1871207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic psychotic illness from methamphetamine.
    Buffenstein A; Heaster J; Ko P
    Am J Psychiatry; 1999 Apr; 156(4):662. PubMed ID: 10200757
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative studies of new anti-migraine drugs. I. Action on central nervous system in rodents.
    Metysová J; Metys J
    Act Nerv Super (Praha); 1979 Oct; 21(3):174-5. PubMed ID: 517096
    [No Abstract]   [Full Text] [Related]  

  • 33. Methamphetamine-induced changes of peripheral catecholamines: an animal experiment to elucidate the cause of sudden death after methamphetamine abuse.
    Fukunaga T; Mizoi Y; Adachi J
    Nihon Hoigaku Zasshi; 1987 Aug; 41(4):335-41. PubMed ID: 3694875
    [No Abstract]   [Full Text] [Related]  

  • 34. Caffeine-Induced Psychosis in a Bodybuilder With Chronic Testosterone and Amphetamine/Dextroamphetamine Misuse.
    Gomes CAB; Mahgoub Y
    Prim Care Companion CNS Disord; 2018 Jun; 20(3):. PubMed ID: 29947481
    [No Abstract]   [Full Text] [Related]  

  • 35. Change of shift. Of masses and men.
    Hirthler MA
    Ann Emerg Med; 2011 Jun; 57(6):692-3. PubMed ID: 21621096
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain.
    Utena H
    Prog Brain Res; 1966; 21():192-207. PubMed ID: 5950502
    [No Abstract]   [Full Text] [Related]  

  • 37. The emotional communication based on methamphetamine mortality as the index in olfactory bulbectomized mice.
    Gomita Y; Kataoka Y
    J Pharmacobiodyn; 1980 May; 3(5):245-9. PubMed ID: 7411386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphetamine toxicity in genetically aggressive and non-aggressive mice.
    Lagerspetz KY; Lagerspetz KM
    J Pharm Pharmacol; 1971 Jul; 23(7):542-3. PubMed ID: 4397457
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence.
    Ando K; Hironaka N; Yanagita T
    Psychopharmacol Bull; 1986; 22(3):763-7. PubMed ID: 3797582
    [No Abstract]   [Full Text] [Related]  

  • 40. Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis.
    Tadokoro S; Kuribara H
    Psychopharmacol Bull; 1986; 22(3):757-62. PubMed ID: 3797581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.